FIASP, FIASP FLEXTOUCH, FIASP PENFILL (Novo Nordisk Pharmaceuticals Pty Ltd)
Product name
FIASP, FIASP FLEXTOUCH, FIASP PENFILL
Date registered
Evaluation commenced
Decision date
Approval time
190 working days (255)
Active ingredients
insulin aspart (rys)
Registration type
EOI
Indication
FIASP, FIASP FLEXTOUCH, FIASP PENFILL (solution for injection) is now also indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.